Jak si vybrat doplněk myo-inositolu: 5 kritérií pro ženy s PCOS a nepravidelností cyklu
Table of Contents
- Key Takeaways
- Why the 40:1 ratio is non-negotiable
- Criterion 1 — The MI:DCI ratio: is it 40:1?
- Criterion 2 — DCI dose precision: 22.5mg is not arbitrary
- Criterion 3 — Folate form: why 6-MTHF is essential
- Criterion 4 — CoQ10 for oocyte mitochondrial quality
- Criterion 5 — Format and dose adequacy
- MyoBalan — the benchmark formula
- Explore MyoBalan with BioEssentials
TL;DR:
- The Myo-Inositol supplement market has proliferated rapidly since clinical evidence for PCOS and cycle support emerged, but most products fail on the most critical formulation criterion: the 40:1 Myo-Inositol to D-Chiro-Inositol ratio.
- Five criteria distinguish a clinically informed Myo-Inositol supplement from a powder or capsule that merely contains the ingredient: the 40:1 ratio, precise DCI dosing, active folate (6-MTHF), CoQ10 inclusion, and format/dose adequacy.
- MyoBalan by BioEssentials satisfies all five: the precise 40:1 ratio with 22.5mg DCI, Folate 6-MTHF 600mcg, CoQ10 150mg, NAC, D3, and Zinc — in a capsule format that avoids the taste and mixing challenges of inositol powders.
Myo-Inositol supplements for PCOS and cycle support represent one of the most evidence-backed but poorly executed categories in women's nutrition. The clinical literature is clear on the rationale — but the translation to commercial products is frequently inadequate. Understanding the five criteria below will allow you to evaluate any inositol product and immediately identify whether it is genuinely formulated for the outcomes the research supports.
Key Takeaways
| Criterion | Benchmark Standard | Common Failure |
|---|---|---|
| MI:DCI ratio | 40:1 — matches follicular fluid physiology | MI only (no DCI) or incorrect ratios (2:1, 5:1, 3.6:1) |
| DCI dose | 22.5mg — derived from total MI dose at 40:1 | Round-number DCI doses (25mg, 50mg, 100mg) — not precision-formulated |
| Folate form | 6-MTHF — active methylfolate, pre-conception ready | Folic acid — inactive form requiring MTHFR conversion |
| CoQ10 inclusion | Present at 100mg+ — oocyte mitochondrial quality | Absent — no oocyte energy support |
| Format | Capsule at full clinical dose (2g+ MI/day) | Powder only — taste compliance issues; or under-dosed capsules |
Why the 40:1 ratio is non-negotiable
Human follicular fluid — the fluid surrounding developing egg follicles in the ovary — naturally contains Myo-Inositol and D-Chiro-Inositol in a ratio of approximately 40:1. This ratio supports optimal FSH receptor signalling (via MI) and insulin-regulated androgen suppression (via DCI) in the granulosa cells. Disrupting this ratio — by using too much DCI relative to MI — depletes follicular MI and actually impairs oocyte quality, as demonstrated in studies using higher DCI proportions.
The 40:1 ratio was identified through analysis of naturally occurring inositol concentrations in follicular fluid and validated in clinical studies by multiple research groups. Any deviation from this ratio — whether through a MI-only formula, an incorrect DCI proportion, or unmeasured DCI content within a blend — represents a departure from the physiologically validated approach. This is the single most important criterion in this category.
Criterion 1 — The MI:DCI ratio: is it 40:1?
This is a simple label check but requires knowing what to look for. A product providing the 40:1 ratio will list both Myo-Inositol and D-Chiro-Inositol (or DCI) as separate ingredients with specified individual quantities. The simplest check: divide the Myo-Inositol dose by the DCI dose. If the result is approximately 40, the product is ratio-correct. If the result is anything else (or if DCI is absent entirely, or if both are listed within a proprietary blend without individual quantities), the product does not meet this criterion.
Examples of non-compliant ratio patterns include: products providing 2,000mg MI and 50mg DCI (40:1 — correct); products providing 2,000mg MI and 500mg DCI (4:1 — too much DCI); products providing 2,000mg MI with no DCI at all (MI only — missing the insulin-signalling synergy). The ratio calculation is the most reliable and straightforward label evaluation tool available for this category.
Criterion 2 — DCI dose precision: 22.5mg is not arbitrary
At the standard clinical MI dose of approximately 2,000mg (with typical evidence from studies using 2g twice daily for 4g total), the 40:1 ratio requires approximately 50mg DCI per 2,000mg MI serving. At half that serving dose, the DCI scales proportionally. The precise dose is calculated mathematically from the ratio, not rounded to a convenient number.
Products using round DCI doses (25mg, 50mg, 100mg) without a corresponding MI dose that produces the 40:1 ratio are not precision-formulated — they are approximating, and the approximation may tip the ratio toward excess DCI. MyoBalan's 22.5mg DCI dose is derived from the precise calculation at the formula's Myo-Inositol dose — a marker of formulation rigour rather than coincidence.
Criterion 3 — Folate form: why 6-MTHF is essential
Folate in a PCOS or cycle support supplement is particularly significant because: a) PCOS is associated with elevated homocysteine levels, which are modulated by folate status; b) the formula is likely used by women in or approaching reproductive years, where pre-conception folate adequacy is critical; c) MTHFR gene variants — which impair folic acid conversion — are more relevant in a reproductive health context than almost any other supplement category.
The difference between folic acid (synthetic, requires MTHFR conversion) and 6-MTHF (active methylfolate, conversion bypassed) is directly relevant here. A formula targeting PCOS and cycle support that uses folic acid instead of 6-MTHF is leaving a significant proportion of its target users under-served — those with MTHFR variants, which are extremely common. 6-MTHF at 600mcg (the dose in MyoBalan) is the gold-standard folate choice for any pre-conception or reproductive health formula.
Criterion 4 — CoQ10 for oocyte mitochondrial quality
Oocyte (egg cell) quality is one of the most significant determinants of reproductive outcome — and it is strongly correlated with mitochondrial function. The oocyte is the largest cell in the human body and contains more mitochondria than any other cell type, reflecting the extraordinary energy requirements of meiosis and early embryonic development. CoQ10 is the critical coenzyme of the mitochondrial electron transport chain — and oocyte CoQ10 levels decline significantly with age, contributing to the age-related decline in oocyte quality.
Including CoQ10 in a cycle support formula — at 100mg or above — directly addresses the oocyte energy dimension that inositol alone does not reach. The combination of the 40:1 MI:DCI ratio (FSH signalling and insulin regulation) with CoQ10 (oocyte mitochondrial energy) creates a more comprehensive ovarian support formula than inositol alone. Most inositol supplements — particularly powders — do not include CoQ10, leaving this important oocyte quality dimension unaddressed.
Criterion 5 — Format and dose adequacy
The majority of the clinical evidence for Myo-Inositol in PCOS uses total daily doses of 2,000 to 4,000mg (typically 2g twice daily). Inositol is commonly sold as a powder for this reason — the dose is large relative to a standard capsule. However, powder formats have compliance challenges: they require preparation, have a taste some users find unpleasant, and are inconvenient for travel. Capsule formats need to provide an adequate number of capsules (or capsules of sufficient size) to deliver the full therapeutic dose.
Formulas providing 500mg or less of Myo-Inositol per serving without clear dosing instructions for reaching therapeutic levels are under-dosing. A capsule-based product should clearly state the total daily MI dose achievable at the recommended serving and should allow users to reach the 2,000 to 4,000mg range that the clinical evidence supports. Dose transparency on the label is the minimum standard.
MyoBalan — the benchmark formula
| Criterion | Standard Inositol Powder | MyoBalan (BioEssentials) |
|---|---|---|
| MI:DCI ratio | ✗ MI only, or non-40:1 ratio | ✓ 40:1 — physiologically validated, precisely calculated |
| DCI dose precision | ✗ Round-number DCI (50mg, 100mg) — not mathematically derived | ✓ 22.5mg DCI — derived from formula MI dose at 40:1 |
| Folate form | ✗ Folic acid — MTHFR conversion dependent | ✓ 6-MTHF 600mcg — active, MTHFR-bypassing form |
| CoQ10 | ✗ Absent — powder format rarely includes CoQ10 | ✓ CoQ10 150mg — oocyte mitochondrial quality support |
| Supporting nutrients | ✗ Inositol only or minimal additions | ✓ NAC 100mg + Vitamin D3 25mcg + Zinc — complete hormonal and metabolic foundation |
Explore MyoBalan with BioEssentials
The five criteria above reduce the evaluation of any Myo-Inositol supplement to a clear, label-readable checklist. Most products on the market fail on at least two — most commonly the 40:1 ratio and CoQ10 inclusion. MyoBalan was built to satisfy all five with formulation precision: the physiologically validated ratio, precise DCI dosing, active folate, and a complete supporting stack including CoQ10, NAC, and D3.
MyoBalan by BioEssentials — 40:1 Myo-Inositol Women's Cycle Support
Frequently asked questions
Does MyoBalan require a PCOS diagnosis to be useful?
No. The 40:1 inositol formula has been studied primarily in women with PCOS, but insulin resistance — a key mechanism it addresses — exists on a spectrum and affects many women without a formal PCOS diagnosis. Women with irregular cycles, elevated androgens, or metabolic features of insulin resistance may benefit from the formula regardless of diagnostic status. For women without reproductive concerns, the pre-conception folate and oocyte quality support remain relevant.
Can MyoBalan be used during IVF preparation?
Myo-Inositol supplementation has been specifically studied in women preparing for IVF, with evidence supporting improvements in ovarian response, oocyte quality, and embryo grade. CoQ10 supplementation is independently studied for oocyte quality improvement in IVF-preparation contexts. Always inform and consult your reproductive medicine team about all supplements being taken during an IVF cycle — their guidance on timing and dose takes precedence over general product recommendations.
How does MyoBalan interact with metformin?
Metformin and Myo-Inositol share some mechanistic overlap — both improve insulin sensitivity and reduce hepatic glucose production. Limited clinical data suggests the combination may be additive rather than competitive, with some studies using both in PCOS populations showing enhanced outcomes. However, combining supplements with prescription medications always warrants medical review — discuss with your prescribing doctor or endocrinologist before using MyoBalan alongside metformin.
Can MyoBalan be taken continuously or only in cycles?
Clinical trials have used continuous Myo-Inositol supplementation for 3 to 12 months without adverse effects, and the ingredient has a well-established long-term safety profile at the doses used in published research. There is no clinical requirement to cycle or interrupt supplementation — consistent daily use is both safe and more effective than intermittent use for the sustained hormonal and metabolic modulation the formula targets.
Is MyoBalan suitable for teenagers with PCOS?
Myo-Inositol has been studied in adolescents with PCOS, with safety and efficacy profiles comparable to adult populations. However, supplement use in teenagers should be supervised by a healthcare professional — particularly given that PCOS in adolescence can be a complex diagnostic and management challenge. Parental and medical guidance is essential for use in individuals under 18.
Recommended
- Multi-pathway liver support: the new standard — BioEssentials
- How to choose an immunity mushroom supplement: 5 criteria — BioEssentials
- Sleep supplements: why the best go beyond melatonin — BioEssentials
- Metabolic flexibility: why blood sugar matters more than calories — BioEssentials
- How to stack magnesium: 5 BioEssentials formulas explained — BioEssentials
Our research and formulas have been recognized by leading media outlets such as Marie Claire.
Scientific References
- Clinical evidence on Inositol efficacy and safety (PubMed)
- Mechanisms of action and bioavailability of Inositol (PMC)
- Evidence-based review: Inositol supplementation outcomes (PubMed)
These statements have not been evaluated by the Food and Drug Administration. BioEssentials products are food supplements intended to support general wellness and daily nutritional needs. They are not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare professional before starting any new supplement if you are pregnant, breastfeeding, taking medication, or managing a health condition.
